Whipple's Disease: Causes, Symptoms, Diagnosis, and Treatment

What is Whipple’s Disease?

Whipple’s disease is a rare but serious systemic bacterial infection capable of affecting multiple organs and body systems. One of its most clinically significant features is its interference with the body’s ability to absorb dietary fats and, as a consequence, many essential vitamins and micronutrients.

Although it is an extremely rare condition, Whipple’s disease can be fatal if not recognized and treated promptly. Its wide range of symptoms, which can mimic many other conditions, often leads to delayed diagnosis. Awareness of this disease is therefore essential for timely intervention.

---

Causes

The Causative Bacterium

Whipple’s disease is caused by the gram-positive bacterium Tropheryma whipplei, first identified and characterized in 1992, although the disease itself was first described clinically in the early 1900s by the American physician George Hoyt Whipple.

Who Is at Risk?

The disease is exceedingly rare, with most documented cases reported in North America and Europe. It appears to disproportionately affect:

• Individuals with a specific genetic predisposition, particularly those carrying the HLA-B27 allele
• People over the age of 50–55
• Men significantly more than women (male-to-female ratio approximately 4:1)

A higher incidence has been noted among agricultural workers, likely reflecting exposure to the bacterium through soil, though the exact routes of transmission remain poorly understood.

How Does Infection Occur?

The precise mechanisms of infection are not fully established. Current evidence suggests that exposure to T. whipplei is actually relatively common in certain environments, but only a minority of exposed individuals develop clinical disease. Many people may carry the bacterium asymptomatically or with only mild, transient symptoms. This points to the importance of host immune factors, particularly cell-mediated immunity, in determining who becomes ill.

There is no evidence of person-to-person transmission, and contact with an infected patient is not considered a risk factor.

What Happens in the Body?

The bacteria primarily attack the mucosal lining of the small intestine, forming small lesions and critically damaging the intestinal villi, the tiny finger-like projections responsible for nutrient absorption. This results in a state of progressive malabsorption, affecting fats, fat-soluble vitamins (A, D, E, K), proteins, carbohydrates, and micronutrients. The bacteria can then spread through the lymphatic system to other organs, leading to the multisystemic manifestations of the disease.

---

Symptoms

Whipple’s disease is a multisystem disorder, and its symptoms can affect the gastrointestinal tract, joints, heart, nervous system, and lymphatic system, often developing slowly over a period of months to years. This gradual progression frequently leads to a significant delay between symptom onset and diagnosis.

Gastrointestinal Symptoms

The classic presentation of Whipple’s disease resembles other malabsorption syndromes and includes:

• Diarrhea
• Abdominal pain that worsens after meals
• Unintentional weight loss
• Fever (present in 30–50% of patients)

The diarrhea typically has the characteristics of steatorrhea (fat malabsorption), including:

• Greasy, oily stools
• Floating stools
• Pale or light-colored appearance
• Strongly foul odor

In some patients, the diarrhea may be watery rather than fatty. Occult gastrointestinal bleeding (not visible to the naked eye) is relatively common, while frank rectal bleeding is rarer.

Reduced protein absorption due to intestinal inflammation, a condition known as protein-losing enteropathy, results in low circulating protein levels, leading to diffuse peripheral edema (swelling).

Joint Symptoms

Joint pain is often one of the earliest symptoms and may precede gastrointestinal complaints by months or even years, making early diagnosis particularly challenging. The pain typically affects large joints such as:

• Ankles
• Knees
• Wrists
• Sacroiliac joints (sacroiliitis)

The arthritis is usually migratory and non-destructive.

Cardiac Symptoms

Approximately one in three patients develops cardiovascular involvement, which may include:

• Pericarditis (inflammation of the sac surrounding the heart)
• Endocarditis (infection of the heart valves)
• Cardiac murmurs
• Congestive heart failure

Cardiac complications can be life-threatening and require careful monitoring.

Hematological Symptoms

Chronic malabsorption of iron, folate, and vitamin B12 leads to anemia, which commonly causes fatigue and muscle weakness.

Enlarged lymph nodes are frequently observed, reflecting the spread of the infection through the lymphatic system.

Neurological Symptoms

Central nervous system involvement is one of the most serious manifestations of Whipple’s disease and can occur even in the absence of gastrointestinal symptoms. Neurological features may include:

• Difficulty walking due to balance disturbances
• Visual disturbances
• Memory problems
• Mental confusion
• Seizures
• Delirium
• Progressive cognitive decline
• Abnormal involuntary movements
• Hypersomnia (excessive and uncontrollable daytime sleepiness)
• Extrapyramidal symptoms (movement abnormalities similar to those seen in Parkinson’s disease)

A particularly characteristic (though rare) neurological finding is oculomasticatory myorhythmia: a rhythmic, pendular convergence of the eyes synchronized with contractions of the jaw muscles, which is considered nearly pathognomonic of Whipple’s disease when present.

Disease Course

Whipple’s disease is a slowly progressive and ultimately debilitating condition if left undiagnosed and untreated. Symptoms typically evolve over years, with joint pain and weight loss often appearing long before digestive complaints prompt medical evaluation. The most serious consequences stem from severe nutritional deficiencies and, if untreated, the disease can be fatal.

---

Diagnosis

Biopsy: The Gold Standard

The definitive diagnosis of Whipple’s disease is made through biopsy of the small intestine, typically obtained via upper endoscopy. The biopsy specimens are examined with periodic acid-Schiff (PAS) staining, which reveals characteristic PAS-positive macrophages containing the bacteria in the intestinal mucosa.

Important: If a patient has been empirically treated with antibiotics before the biopsy, this may produce a false-negative result by reducing the bacterial load below detectable levels. Clinicians should ideally obtain the biopsy before starting antibiotic therapy when Whipple’s disease is suspected.

Polymerase chain reaction (PCR) testing for T. whipplei DNA can be performed on biopsy specimens, cerebrospinal fluid, or other tissues. PCR is particularly valuable when:

• Standard histology is inconclusive
• Neurological involvement is suspected
• Monitoring response to treatment

Laboratory Abnormalities

Routine blood tests often reveal multiple abnormalities reflecting the extent of malabsorption and systemic inflammation, including:

Additional Investigations

Depending on the clinical presentation, additional tests may include:

• CT scan or MRI of the abdomen and brain to assess lymphadenopathy, CNS involvement, or organ complications
• Echocardiography if cardiac involvement is suspected
• Lumbar puncture (cerebrospinal fluid analysis with PCR) when neurological symptoms are present

---

Treatment

Antibiotic Therapy: The Cornerstone of Treatment

The primary and highly effective treatment for Whipple’s disease is antibiotic therapy. The treatment protocol is carefully designed to penetrate the central nervous system, regardless of whether neurological symptoms are present, in order to prevent or treat CNS involvement.

Standard Treatment Protocol:

1. Induction phase (2 weeks):

   • Ceftriaxone 2 g intravenously once daily
   • (Alternative: Meropenem or penicillin G for patients who cannot receive ceftriaxone)

2. Maintenance phase (12 months):

   • Trimethoprim/Sulfamethoxazole (TMP-SMX) orally twice daily
   • This prolonged course is essential to prevent relapse, which can occur even years after initial treatment

For patients with sulfonamide allergy, doxycycline with hydroxychloroquine is an accepted alternative regimen.

Prognosis

With appropriate antibiotic treatment, the prognosis is generally favorable. Most patients begin to show clinical improvement, particularly in gastrointestinal symptoms and weight, within 2 to 3 weeks of starting therapy.

However, neurological symptoms may be slower to resolve or may not fully recover, particularly if CNS involvement was present at the time of diagnosis. This underscores the importance of early diagnosis.

Relapse rates are significant, particularly in the CNS, and patients should be monitored with follow-up biopsies and clinical assessments during and after treatment. Some patients may require long-term or even lifelong low-dose maintenance therapy.

Supportive Care

In addition to antibiotics, supportive measures are important, especially in the early stages of treatment:

• Nutritional rehabilitation: Correction of deficiencies in iron, vitamins (particularly A, D, E, K, and B12), and other micronutrients
• Management of complications: Treatment of heart failure, seizures, or other organ-specific complications as they arise

---

Sources and Bibliography

• National Institutes of Health – Rare Diseases (NIH GARD): Whipple Disease
• Whipple Disease – Catiele Antunes; Mayank Singhal. StatPearls, NCBI Bookshelf.
• Fenollar F, Puéchal X, Raoult D. “Whipple’s disease”. New England Journal of Medicine. 2007;356(1):55-66. PMID: 17202456
• Marth T, Moos V, Müller C, Biagi F, Schneider T. “Tropheryma whipplei infection and Whipple’s disease”. Lancet Infectious Diseases. 2016;16(3):e13-e22. PMID: 26856775
• Dolmans RA, Boel CH, Lacle MM, Kusters JG. “Clinical Manifestations, Treatment, and Diagnosis of Tropheryma whipplei Infections”. Clinical Microbiology Reviews. 2017;30(2):529-555. PMID: 28298472
• Orphanet: Whipple Disease